To access the full text documents, please follow this link: http://hdl.handle.net/2445/144567

Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Rodríguez, Alejandro H.; Avilés Jurado, Francesc X.; Díaz, Emili; Schuetz, Philipp; Trefler, Sandra I.; Solé Violán, Jordi; Cordero, Lourdes; Vidaur, Loreto; Estella, Ángel; Pozo Laderas, Juan C.; Socias, Lorenzo; Vergara, Juan C.; Zaragoza, Rafael; Bonastre, Juan; Guerrero, José Eugenio; Suberviola, Borja; Cillóniz, Catia; Restrepo, Marcos I.; Martín Loeches, Ignacio; SEMICYUC/GETGAG Working Group
Objectives: To define which variables upon ICU admission could be related to the presence of coinfection using CHAID (Chi-squared Automatic Interaction Detection) analysis. Methods: A secondary analysis from a prospective, multicentre, observational study (2009-2014) in ICU patients with confirmed A(H1N1)pdm09 infection. We assessed the potential of biomarkers and clinical variables upon admission to the ICU for coinfection diagnosis using CHAID analysis. Performance of cut-off points obtained was determined on the basis of the binominal distributions of the true (+) and true (−) results. Results: Of the 972 patients included, 196 (20.3%) had coinfection. Procalcitonin (PCT; ng/mL 2.4 vs. 0.5, p < 0.001), but not C-reactive protein (CRP; mg/dL 25 vs. 38.5; p = 0.62) was higher in patients with coinfection. In CHAID analyses, PCT was the most important variable for coinfection. PCT <0.29 ng/mL showed high sensitivity (Se = 88.2%), low Sp (33.2%) and high negative predictive value (NPV = 91.9%). The absence of shock improved classification capacity. Thus, for PCT <0.29 ng/mL, the Se was 84%, the Sp 43% and an NPV of 94% with a post-test probability of coinfection of only 6%. Conclusion: PCT has a high negative predictive value (94%) and lower PCT levels seems to be a good tool for excluding coinfection, particularly for patients without shock.
-Influenzavirus
-Pèptids
-Influenza viruses
-Peptides
cc-by-nc-nd (c) The British Infection Association, 2016
http://creativecommons.org/licenses/by-nc-nd/3.0/es
Article
Article - Accepted version
Elsevier
         

Show full item record

Related documents

Other documents of the same author

Rodríguez, Alejandro H.; Avilés Jurado, Francesc X.; Díaz, Emili; Schuetz, Philipp; Trefler, Sandra I.; Solé Violán, Jordi; Cordero, Lourdes; Vidaur, Loreto; Estella, Ángel; Pozo Laderas, Juan C.; Socias, Lorenzo; Vergara, Juan C.; Zaragoza, Rafael; Bonastre, Juan; Guerrero, José E.; Suberviola, Borja; Cillóniz, Catia; Restrepo, Marcos I.; Martín Loeches, Ignacio; SEMICYUC/GETGAG Working Group
Rodríguez, Alejandro H.; Avilés Jurado, Francesc X.; Díaz, Emili; Schuetz, Philipp; Trefler, Sandra I.; Solé Violán, Jordi; Cordero, Lourdes; Vidaur, Loreto; Estella, Ángel; Pozo Laderas, Juan C.; Socias, Lorenzo; Vergara, Juan C.; Zaragoza, Rafael; Bonastre, Juan; Guerrero, José E.; Suberviola, Borja; Cillóniz, Catia; Restrepo, Marcos I.; Martín Loeches, Ignacio; SEMICYUC/GETGAG Working Group
Martín Loeches, Ignacio; Díaz, Emili; Vidaur, Loreto; Torres Martí, Antoni; Laborda, César; Granada, Rosa; Bonastre, Juan; Martín, Mar; Insausti, Josu; Arenzana, Angel; Guerrero, José Eugenio; Navarrete, Inés; Bermejo Martín, Jesús; Suárez, David; Rodríguez, Alejandro; H1N1 SEMICYUC/REIPI/CIBERES Working Group
Martín Loeches, Ignacio; Díaz, Emili; Vidaur, Loreto; Torres Martí, Antoni; Laborda, César; Granada, Rosa; Bonastre, Juan; Martín, Mar; Insausti, Josu; Arenzana, Angel; Guerrero, José Eugenio; Navarrete, Inés; Bermejo Martín, Jesús; Suárez, David; Rodríguez, Alejandro; H1N1 SEMICYUC/REIPI/CIBERES Working Group
Martin Loeches, Ignacio; Papiol, Elisabeth; Rodríguez, Alejandro; Diaz, Emili; Zaragoza, Rafael; Granada, Rosa; Socias, Lorenzo; Bonastre, Juan; Valverdú, Montserrat; Pozo, Juan Carlos; Luque, Pilar; Juliá Narvaéz, Jose Antonio; Cordero, Lourdes; Albaya, Antonio; Serón, Daniel; Rello, Jordi; H1N1 SEMICYUC Working Group
 

Coordination

 

Supporters